Cure8 research brief
Why This Matters
The study suggests ADHD and autism are linked with slightly higher risk of more severe IBD events (including need for advanced therapies and, for UC, colectomy), which may help target monitoring and support for young patients.
Who Should Pay Attention
Pediatric and young-adult IBD patients with ADHD or autism, their parents/caregivers, pediatric gastroenterologists, and researchers studying neurodevelopmental comorbidity in IBD.
Study Snapshot
What To Know
This Danish cohort compared 785 young people with both IBD and ADHD/autism to 6,729 with IBD alone using registry data from 1996–2022. Severe disease activity was defined broadly (advanced therapies, oral corticosteroids, IBD-related surgery, hospitalization).
Overall 10-year cumulative incidence of severe activity was slightly higher in the ADHD/autism group (36.2% vs 33.7%). The study found a small increased risk of receiving advanced IBD therapies and a higher risk of colectomy among patients with ulcerative colitis who also had ADHD/autism, particularly when IBD onset occurred before age 18.
How to think about this These findings suggest clinicians and families might consider closer monitoring or tailored support for young patients with IBD who also have ADHD or autism, but the differences reported were generally modest and do not imply a specific treatment change.
Keep In Mind
This is an observational registry study from Denmark; associations do not prove causation. “Severe disease activity" was a composite outcome that included treatment escalation and hospital-based events. The effects reported were generally small (adjusted hazard ratios near 1.2–1.7).
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.